Grigorios Siokas Acquires 218,447 Shares of Cosmos Health (NASDAQ:COSM) Stock

Cosmos Health Inc. (NASDAQ:COSM) CEO Grigorios Siokas purchased 218,447 shares of Cosmos Health stock in a transaction dated Thursday, June 11th. The shares were acquired at an average cost of $0.21 per share, for a total transaction of $45,873.87. Following the completion of the transaction, the chief executive officer owned 13,481,808 shares of the company’s stock, valued at approximately $2,831,179.68. This represents a 1.65% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

Grigorios Siokas also recently made the following trade(s):

• On Wednesday, June 10th, Grigorios Siokas purchased 701,447 shares of Cosmos Health stock. The shares were acquired at an average cost of $0.23 per share, for a total transaction of $161,332.81.

Cosmos Health Stock Performance

Shares of COSM stock opened at $0.21 on Friday. The business’s fifty day simple moving average is $0.30 and its 200-day simple moving average is $0.40. The company has a market cap of $13.04 million, a PE ratio of -0.33 and a beta of 4.79. The company has a current ratio of 1.08, a quick ratio of 0.92 and a debt-to-equity ratio of 0.31. Cosmos Health Inc. has a 12-month low of $0.20 and a 12-month high of $1.32.

Cosmos Health (NASDAQ:COSM) last issued its quarterly earnings results on Thursday, May 21st. The company reported ($0.06) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.06). Cosmos Health had a negative return on equity of 52.85% and a negative net margin of 30.41%.The business had revenue of $18.40 million for the quarter, compared to the consensus estimate of $17.93 million. Analysts expect that Cosmos Health Inc. will post -0.06 earnings per share for the current fiscal year.

Trending Headlines about Cosmos Health

Here are the key news stories impacting Cosmos Health this week:

• Positive Sentiment: The company reported annualized sales above $1.5 million for its C-Scrub and C-Sept antiseptic brands in the UK and Greece, and outlined EU expansion plans that could target $7.4 million in revenue and $5.3 million in gross profit by 2028. Article Title
• Positive Sentiment: Cosmos Health announced new contract manufacturing orders totaling 253,657 units, adding to evidence that its Cana subsidiary is seeing steady commercial demand across multiple medicines and pharmaceutical products. Article Title
• Positive Sentiment: CEO Grigorios Siokas made additional open-market share purchases, which investors often view as a signal of management confidence in the company’s outlook. Article Title
• Positive Sentiment: The company signed a letter of intent to acquire Doc Pharma S.A., a GMP manufacturer, a move that could expand assets, production capacity, margins, and its product portfolio if completed. Article Title

Hedge Funds Weigh In On Cosmos Health

Hedge funds have recently made changes to their positions in the company. Renaissance Technologies LLC increased its position in shares of Cosmos Health by 260.5% in the 4th quarter. Renaissance Technologies LLC now owns 334,575 shares of the company’s stock valued at $167,000 after acquiring an additional 241,775 shares during the period. Citadel Advisors LLC increased its position in shares of Cosmos Health by 133.1% in the 3rd quarter. Citadel Advisors LLC now owns 225,507 shares of the company’s stock valued at $250,000 after acquiring an additional 128,776 shares during the period. Finally, XTX Topco Ltd increased its position in shares of Cosmos Health by 52.1% in the 4th quarter. XTX Topco Ltd now owns 99,610 shares of the company’s stock valued at $50,000 after acquiring an additional 34,117 shares during the period. 12.61% of the stock is owned by institutional investors and hedge funds.

Cosmos Health Company Profile

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.